Genmab · 9 hours ago
Director, Center for Outcomes Research, Real World Evidence and Epidemiology, Global/US CORE
Princeton, NJ
Full-time
Hybrid
Director/Executive
$216K/yr - $324K/yr
10+ years expGenmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Director of the Center for Outcomes Research will be responsible for developing and executing health economics and outcomes research strategy for oncology products, ensuring alignment with brand and market access strategies.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Develop and implement Global/US CORE strategy and plan for oncology product in alignment with brand, medical and market access strategy
Conduct relevant research to demonstrate value of oncology product
Manage research projects that are customer facing including RWE generation with customers
Ensure all research is conducted with a high level of scientific rigor
Train field access and field HEOL/MSL teams on customer facing material as appropriate
Develop customer facing materials (eg: FDAMA-114, FM decks with HEOR data) and tools (eg: BIMs, cost calculators) that can communicate value to payer customer in partnership with Medical Communications Team
Contribute to publication strategies for given product present research at scientific conferences and forums
Communicate value evidence to key access customers as needed to ensure patient access, medical policy, coverage, and reimbursement for oncology product
As a member of the CORE team, contribute to department strategy and objectives as well as represent CORE on key initiatives
As a member of the CORE team, support pipeline assets as needed
Qualification
Required
Graduate (Masters) degree and relevant work experience in health economics, outcomes research, epidemiology, health services research, public health, health policy
Minimum of 10 years in the pharmaceutical industry or a managed care setting in the direct conduct of health economics, outcomes research, real world evidence and epidemiology studies
Must possess the ability to understand healthcare marketplace, access trends and communication strategies with access customers and influencers
Must have a proven ability to build customer relationships
Demonstrated strong problem solving and communications skills
Flexibility to travel is required
Strong commercial and clinical strategic mindset
Demonstrated research accomplishments as evidenced by a history of peer-reviewed publications
Ability to work well in a team and cross-functional environment, as well as work independently with limited supervision
Ability to work successfully under pressure in a fast-paced environment and with tight timelines
Ability to be proactive, enthusiastic and goal orientated
Strong communication skills - both oral and written
Preferred
Oncology experience preferred
Benefits
401(k) Plan: 100% match on the first 6% of contributions
Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
1001-5000 employees
H1B Sponsorship
Genmab has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (10)
2023 (6)
2022 (3)
2021 (3)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Leadership Team
Anthony Pagano
Chief Financial Officer
Anthony Mancini
EVP & Chief Operating Officer
Recent News
2025-12-31
2025-12-30
2025-12-30
Company data provided by crunchbase